A novel POLD1 pathogenic variant identified in two families with a cancer spectrum mimicking Lynch syndrome
Clémentine Legrand(Centre Hospitalier Universitaire de Grenoble), Qing Wang(Centre Léon Bérard), Magalie Peysselon, Pierre Naïbo(Hospices Civils de Lyon), Vincent Goussot(Centre Georges François Leclerc), Sandrine Handallou(Centre Léon Bérard), Sophie Nambot(Université de Bourgogne), Fabienne Prieur(Centre Hospitalier Universitaire de Saint-Étienne), Françoise Desseigne(Centre Léon Bérard), Nadim Hamzaoui(Hôpital Cochin), Jean‐Marc Rey(Université de Montpellier), Marine Lebrun(Hôpital Nord)
Cited by 3
Related Papers
Delineating the <i>GRIN1</i> phenotypic spectrum
|Neurology|2016|211
Clinical practice guidelines for BRCA1 and BRCA2 genetic testing
|European Journal of Cancer|2021|174
BCL11B mutations in patients affected by a neurodevelopmental disorder with reduced type 2 innate lymphoid cells
|Brain|2018|135
De novo loss-of-function KCNMA1 variants are associated with a new multiple malformation syndrome and a broad spectrum of developmental and neurological phenotypes
|Human Molecular Genetics|2019|91
Supernumerary marker chromosomes management in prenatal diagnosis
|American Journal of Medical Genetics Part A|2008|85